Probing gut‐brain links in Alzheimer's disease with rifaximin

Gut‐microbiome‐inflammation interactions have been linked to neurodegeneration in Alzheimer's disease (AD) and other disorders. We hypothesized that treatment with rifaximin, a minimally absorbed gut‐specific antibiotic, may modify the neurodegenerative process by changing gut flora and reducin...

Descripción completa

Detalles Bibliográficos
Autores principales: Suhocki, Paul V., Ronald, James S., Diehl, Anna Mae E., Murdoch, David M., Doraiswamy, P. Murali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804600/
https://www.ncbi.nlm.nih.gov/pubmed/35128026
http://dx.doi.org/10.1002/trc2.12225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804600/
https://www.ncbi.nlm.nih.gov/pubmed/35128026
http://dx.doi.org/10.1002/trc2.12225

Ejemplares similares